Xi Chen
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- RNA modifications and cancer 13
- Ubiquitin and proteasome pathways 12
- Epidemiology 60
- Autophagy in Disease and Therapy 36
- Co-authors
- Jack L. Strominger (5 shared papers)Xiao-Ming Yin (6 shared papers)Konrad Krzewski (4 shared papers)Xiangfeng Cong (7 shared papers)Hao Zhang (2 shared papers)Jie Zhou (3 shared papers)Min Li (1 shared paper)Xiwen Xiong (1 shared paper)
- Journals
- PLoS ONE (11 papers)Biochemical and Biophysical Research Communications (7 papers)Oncotarget (6 papers)Scientific Reports (5 papers)Frontiers in Oncology (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xi Chen
331 papers receiving 8.4k citations
Xi Chen's Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 1.2k
- Immunology 1.4k
- Molecular Biology 3.4k
- Oncology 1.2k
- Complementary and alternative medicine 310
Countries citing papers authored by Xi Chen
This map shows the geographic impact of Xi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chen more than expected).
Fields of papers citing papers by Xi Chen
This network shows the impact of papers produced by Xi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chen. The network helps show where Xi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 361 | |
| 2 | Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression Hit paper breakdown → | 2019 | 321 |
| 3 | 2011 | 296 | |
| 4 | 2014 | 268 | |
| 5 | 2017 | 222 | |
| 6 | 2013 | 210 | |
| 7 | 2011 | 172 | |
| 8 | 2012 | 151 | |
| 9 | 2010 | 138 | |
| 10 | 2015 | 138 | |
| 11 | 2013 | 114 | |
| 12 | 2006 | 109 | |
| 13 | 2012 | 107 | |
| 14 | 2007 | 106 | |
| 15 | 2018 | 103 | |
| 16 | 2008 | 103 | |
| 17 | 2022 | 102 | |
| 18 | 2007 | 98 | |
| 19 | 2019 | 93 | |
| 20 | 2018 | 92 |
About Xi Chen
Xi Chen is a scholar working on Molecular Biology, Epidemiology, Oncology, Cell Biology and Immunology, having authored 346 papers that have together received 8.5k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (36 papers), Immune Cell Function and Interaction (18 papers), Hippo pathway signaling and YAP/TAZ (15 papers), Endoplasmic Reticulum Stress and Disease (15 papers), Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (13 papers), Ubiquitin and proteasome pathways (12 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Cancer Research (1.2k citations), Immunology (1.4k citations), Molecular Biology (3.4k citations), Oncology (1.2k citations) and Complementary and alternative medicine (310 citations). Xi Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jack L. Strominger, Xiao-Ming Yin, Konrad Krzewski, Xiangfeng Cong, Hao Zhang, Jie Zhou, Min Li, Xiwen Xiong, Zhengping Wu and Xiaoyun Chen. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications, Oncotarget, Scientific Reports and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.